Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Explorer Kit
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
USA diagnostic Company signs EpiSwitch™ development Agreement for Alzheimer's and Parkinson's diseases.
July 10, 2011
|
In
Milestones
|
By
Catia Gaspar
Prev
Next
Privacy Preference Center
Privacy Preferences
